Mental Practice Versus Proprioceptive Neuromuscular Facilitation on Strength of Upper Limb

NCT ID: NCT03759080

Last Updated: 2019-05-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2018-05-08

Study Completion Date

2018-08-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The effects of mental practice combined with proprioceptive neuromuscular facilitation on muscle strength of upper limb were measured in 60 healthy students Subjects were randomly assigned to either proprioceptive neuromuscular facilitation (PNF) group or mental practice (MP) group. PNF group: 30 individuals, these subjects received only PNF training. MP: 30 individuals, these subjects received mental practice.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The effects of mental practice on muscle strength of upper limb were measured in 60 healthy female students with right dominant hand,. Their age ranged from17 to 23 years old. Subjects were randomly assigned to either proprioceptive neuromuscular facilitation (PNF) group or mental practice (MP) group. PNF group: 30 individuals, these subjects received only PNF training. MP: 30 individuals, these subjects received MP. training program has been administered for every group for 12 sessions over 4 weeks with 3 x 45 min training sessions per week. Pre-post test design was used. EMG device was used to measure the electrical activity of muscles. Measurements conducted at pre-intervention, during intervention and post-intervention testing with 20 days.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Motor Activity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

there are two arms :1. proprioceptive neuromuscular facilitation (PNF) group ,2 mental practice (MP) group.

PNF group: 30 individuals, these subjects received PNF training. PNFMP: 30 individuals, these subjects receivedMP. training program has been administered for every group for 12 sessions over 4 weeks with 3 x 45 min training sessions per week.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

intervention of PNF

PNF group: 30 individuals, these subjects received proprioceptive neuromuscular facilitation training.

Group Type ACTIVE_COMPARATOR

proprioceptive neuromuscular facilitation

Intervention Type PROCEDURE

upper limb Pattern: Flexion -Abduction- External rotation

MP

PNFMP group:30 individuals, these subjects received mental practice.

Group Type EXPERIMENTAL

mental practice

Intervention Type PROCEDURE

training of mental practice to do the pattern of proprioceptive neuromuscular facilitation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

mental practice

training of mental practice to do the pattern of proprioceptive neuromuscular facilitation

Intervention Type PROCEDURE

proprioceptive neuromuscular facilitation

upper limb Pattern: Flexion -Abduction- External rotation

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

MP PNF

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1.Absence of a prior injury of arm

Exclusion Criteria

1.History of a neurological disease.
Minimum Eligible Age

17 Years

Maximum Eligible Age

23 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wafaa Mahmoud Amin

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Wafaa Mahmoud Amin

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jazan University

Riyadh, Jazan Region, Saudi Arabia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Saudi Arabia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2265749560

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.